Breaking News

Cytovance Biologics Expands Services with In-House Formulation Development

This expansion provides an integrated one-stop shop approach for existing and future clients.

By: Rachel Klemovitch

Assistant Editor

Cytovance Biologics, a U.S.-based Contract Development and Manufacturing Organization (CDMO), has launched in-house formulation development services, reinforcing the company’s position as a full-service partner for biologic drug developers. This expansion reflects Cytovance’s continued investment in innovation and commitment to delivering comprehensive solutions for complex development challenges. The new services are available to support existing and future client programs.  “Our for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters